Sign In
Buy LLY
$1,185.71
-7.09 (-0.594%)
At Close: Aug 07, 2026
4 Reasons Why 2024 Could Be Eli Lilly's Worst Year for the Rest of This Decade
05:50am, Thursday, 08'th Feb 2024
Two of Lilly's top-selling drugs could face challenges this year. Many patients won't have access to the company's biggest growth driver of the future.
The decline in Eli Lilly can be attributed to 'authentic stupidity', says Jim Cramer
07:53pm, Wednesday, 07'th Feb 2024
'Mad Money' host Jim Cramer talks Eli Lilly, Apple, and action in the markets that doesn't make sense.
Jim Cramer says recent moves in Apple, Chipotle and Eli Lilly shares don't make sense
07:01pm, Wednesday, 07'th Feb 2024
"When you see some action that doesn't make sense, keep in mind that authentic stupidity is a perfectly plausible explanation," CNBC's Jim Cramer said.
Eli Lilly Agrees To Donate Insulin To Clinics Across Minnesota In Lawsuit Settlement
04:43pm, Wednesday, 07'th Feb 2024
Minnesota Attorney General Keith Ellison announced Wednesday that pharmaceutical giant Eli Lilly will donate insulin to clinics around the state for the next five years—and keep a $35 price cap for
Liver Disease Biotechs Dive on Eli Lilly Data
03:48pm, Wednesday, 07'th Feb 2024
MASH is an advanced liver disorder that can lead to cancer or liver failure.
Eli Lilly settles Minnesota lawsuit over insulin pricing
10:23am, Wednesday, 07'th Feb 2024
Eli Lilly has settled a lawsuit by Minnesota that accused the three largest insulin makers of deceptively raising the price of insulin, which is used to treat diabetes.
Three-Stock Lunch: Eli Lilly, Spotify and Chipotle
02:54pm, Tuesday, 06'th Feb 2024
Courtney Garcia, Payne Capital Management senior wealth advisor, joins 'Power Lunch' to discuss three stocks: Eli Lilly, Spotify and Chipotle.
Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks
02:48pm, Tuesday, 06'th Feb 2024
The trillion-dollar market valuation club is currently dominated by the tech sector. Saudi Aramco is the sole exception.
Healthy Returns: Novo Nordisk, Eli Lilly are tackling weight loss drug supply woes
02:13pm, Tuesday, 06'th Feb 2024
Novo Nordisk and Eli Lilly are working to increase supply of their popular weight loss drugs. Meanwhile, the implantable neurotechnology field is heating up.
Eli Lilly (LLY) Hits High After Earnings & Tesla (TSLA) Higher
02:00pm, Tuesday, 06'th Feb 2024
Eli Lilly (LLY) hits all-time high after earnings. Its 4Q adjusted EPS came in at $2.49 versus an estimated $2.50 and revenue came in at $9.35B versus an estimated $8.86B.
Compared to Estimates, Lilly (LLY) Q4 Earnings: A Look at Key Metrics
12:31pm, Tuesday, 06'th Feb 2024
While the top- and bottom-line numbers for Lilly (LLY) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare t
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
12:06pm, Tuesday, 06'th Feb 2024
The results add to a long list of potential health benefits of tirzepatide besides helping patients shed significant pounds and regulate blood sugar.
Eli Lilly (LLY) Q4 Earnings Beat, Mounjaro, Zepbound Drive Sales
11:51am, Tuesday, 06'th Feb 2024
Eli Lilly (LLY) beats fourth-quarter estimates for earnings as well as sales. The company issues an upbeat guidance for 2024.
Earnings, Fed Speakers Dominate Activity; Lilly Beats, Spotify Misses
11:46am, Tuesday, 06'th Feb 2024
Investors of Lilly (LLY) are responding to the eye-opening efficacy of obesity drugs Mounjaro and Zepbound.
Why Eli Lilly Stock Jumped as Much as 5.1% Today Then Gave Up Its Gains
11:41am, Tuesday, 06'th Feb 2024
Eli Lilly handily beat Wall Street estimates with its Q4 results. The midpoint of the company's full-year 2024 revenue guidance range also topped the average analysts' estimate.
